Get started
Author

Chris Davis

Observed names: C S Davis, C. Davis
ORCID: 0009-0009-2377-5590
Observed ORCID: 0009-0009-2377-5590
OpenAlex ID: A5024334193
High Risk of Death Due to Bacterial and Fungal Infection among Cytomegalovirus (CMV)–Seronegative Recipients of Stem Cell Transplants from Seropositive Donors: Evidence for Indirect Effects of Primary CMV Infection
2002 · W. Garrett Nichols, Lawrence Corey, et al. · The Journal of Infectious Diseases · 422
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
2001 · W. Garrett Nichols, Lawrence Corey, et al. · Blood · 290
PDF
Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
1997 · K D Heckman, G J Weiner, et al. · Journal of Clinical Oncology · 284
Neutropenia in Allogeneic Marrow Transplant Recipients Receiving Ganciclovir for Prevention of Cytomegalovirus Disease: Risk Factors and Outcome
1997 · Bernd Salzberger, Raleigh A. Bowden, et al. · Blood · 227
BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients
2005 · Veronique Erard, Hyung Woo Kim, et al. · Blood · 167
PDF
Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival
2003 · Benedetto Bruno, Theodore Gooley, et al. · Transplantation and Cellular Therapy · 152
PDF
Secondary failure of platelet recovery after hematopoietic stem cell transplantation
2001 · Benedetto Bruno, Theodore Gooley, et al. · Transplantation and Cellular Therapy · 123
PDF
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML
2022 · Gabrielle Paras, Linde M. Morsink, et al. · Blood · 85
PDF
Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation
2009 · Hirohisa Nakamae, Katharine A. Kirby, et al. · Transplantation and Cellular Therapy · 80
PDF
Toxicity and Efficacy of Daily Dapsone as Pneumocystis jiroveci Prophylaxis after Hematopoietic Stem Cell Transplantation: A Case-Control Study
2005 · Dario Sangiolo, Barry Storer, et al. · Transplantation and Cellular Therapy · 76
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal
2018 · Ang Li, Qian Wu, et al. · Transplantation and Cellular Therapy · 75
The Problem of Thrombocytopenia after Hematopoietic Stem Cell Transplantation
1996 · Richard A. Nash, Ted Gooley, et al. · Stem Cells · 74
Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies
2016 · Farah Sahoo, Joshua A. Hill, et al. · Transplantation and Cellular Therapy · 50
PDF
EASIX-1year and late mortality after allogeneic stem cell transplantation
2023 · Lambros Kordelas, Tobias Terzer, et al. · Blood Advances · 46
PDF
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
2020 · Linde M. Morsink, Brenda M. Sandmaier, et al. · Cancers · 41
PDF
Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation
2019 · Kareem Jamani, Qianchuan He, et al. · Transplantation and Cellular Therapy · 36
The Problem of Thrombocytopenia after Hematopoietic Stem Cell Transplantation
1996 · Richard A. Nash, Ted Gooley, et al. · The Oncologist · 35
PDF
Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study
2020 · Ang Li, Pavan K. Bhatraju, et al. · Transplantation and Cellular Therapy · 27
PDF
Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
2017 · Ang Li, Chris Davis, et al. · Blood Advances · 25
HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
2021 · Kylee L. Martens, Wilson L. da Costa, et al. · Blood Advances · 24
PDF
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
2022 · Eduardo Rodríguez-Arbolí, Megan Othus, et al. · Haematologica · 21
PDF
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
2022 · Lucas C. Zarling, Megan Othus, et al. · Leukemia · 20
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
2024 · Naveed Ali, Megan Othus, et al. · Blood Advances · 19
Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
2022 · Corentin Orvain, Mariia Byelykh, et al. · Transplantation and Cellular Therapy · 18
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation
2021 · Kylee L. Martens, Christopher I. Amos, et al. · American Journal of Hematology · 17
PDF
Works count: 74
Citation count: 2,526
H-index: 21
I10-index: 29
Year
Topic
Type